Watchlist Price Alert

Dynavax Technologies Corp... (DVAX)

NASDAQ: DVAX · Real-Time Price · USD

9.47

-0.22 (-2.27%)

At close: May 09, 2025, 3:33 PM

-2.27% (1D)

Bid	9.47
Market Cap	1.14B
Revenue (ttm)	277.25M
Net Income (ttm)	27.31M
EPS (ttm)	-0.5
PE Ratio (ttm)	-18.95
Forward PE	17.38
Analyst	Buy

Ask	9.48
Volume	1,217,871
Avg. Volume (20D)	2,638,668
Open	9.73
Previous Close	9.69
Day's Range	9.45 - 9.87
52-Week Range	9.44 - 14.63
Beta	1.26

About DVAX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DVAX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Dynavax has released their quartely earnings on May 6, 2025:

Revenue of $68.16M misses estimates by $226K, with 34.21% YoY growth.

EPS of -0.11 misses estimates by -0.13, with -57.14% YoY decline.

Why Price Moved

2 days ago

-10.99%

Dynavax Technologies shares are trading lower afte... Unlock content with Pro Subscription

3 weeks ago

-6.66%

Shares of vaccine stocks are trading lower after CDC advisers begins a review of vaccine guidelines and discussed a more narrow use of COVID-19 booster shots.

News

1 day ago · zacks.com

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why

Dynavax Technologies (DVAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 days ago · seekingalpha.com

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Technologies Corporation (NASDAQ:DVAX ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Paul Cox - Vice President, Investor Relations & Corporate Communications Ry...

3 days ago · zacks.com

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

Dynavax Technologies (DVAX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.07 per share a year ago.

2 weeks ago · businesswire.com

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dy...

3 weeks ago · businesswire.com

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”) is one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“...

1 month ago · zacks.com

Why Dynavax Technologies (DVAX) Stock Might be a Great Pick

Dynavax Technologies (DVAX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

2 months ago · seekingalpha.com

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Dynavax Technologies posted solid Q4 results and FY 2025 guidance late in February, with Heplisav-B driving revenue growth and profitability. Heplisav-B's market share continues to grow due to its sup...

2 months ago · zacks.com

Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet

The mean of analysts' price targets for Dynavax Technologies (DVAX) points to an 81.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...

2 months ago · seekingalpha.com

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Dynavax Technologies Corporation (NASDAQ:DVAX ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Paul Cox - Vice President, Investor Relations & Corporate Communicati...

2 months ago · zacks.com

Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates

Dynavax Technologies (DVAX) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to break-even earnings per share a year ago.

Load More News